Your email has been successfully added to our mailing list.

×
-0.00716757291151753 -0.00716757291151753 -0.00716757291151753 -0.0084033613445379 -0.013840830449827 -0.0259515570934255 -0.0247157686604053 -0.018783984181908
Stock impact report

Currency weighs on GlaxoSmithKline Q1 sales and earnings [Reuters]

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
Company Research Source: Reuters
Currency weighs on GlaxoSmithKline Q1 sales and earnings | Reuters Reuters Staff 1 Min Read LONDON, April 25 (Reuters) - Drugmaker GlaxoSmithKline reported a 2 percent fall in both sales and earnings in the first quarter on Wednesday as a stronger pound offset a promising start for its new shingles vaccine Shingrix. GSK’s adjusted earnings per share were 24.6 pence on sales of 7.22 billion pounds ($10.07 billion). Analysts, on average, had forecast 24.25 pence and 7.24 billion pounds, according to Thomson Reuters data. ($1 = 0.7168 pounds) (Reporting by Ben Hirschler, editing by Louise Heavens) All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved. Show less Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GSK alerts
Opt-in for
GSK alerts

from News Quantified
Opt-in for
GSK alerts

from News Quantified